Products for Research Use Only
RegisterLogin

Ripertamab

CAT: 0804-HY-P99952-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99952-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL) [1].
CAS Number
2249927-04-4
Product Name Alternative
SCT400
UNSPSC
12352203
Target
CD20
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ripertamab.html
Purity
99.91
Solubility
H2O
Smiles
[Ripertamab]
Molecular Weight
(144.56 kDa)
References & Citations
[1]Kaplon H, et al. Antibodies to watch in 2022. MAbs. 2022 Jan-Dec;14 (1) :2014296.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
abx831682-01Ripertamab
GTR18338002-01Ripertamab Antibody
A2805-1mg*5Ripertamab (Anti-CD20)
E55B0316Ripertamab (Reference antibody)
HY257076-01Research Grade Ripertamab
047930CD20 (ripertamab) discontinued
F1178-50Anti-CD20 Antibody (Ripertamab)
ICH5826-10mgRipertamab Biosimilar - Research Grade
GTR18697933-01Ripertamab Chimeric Monoclonal Antibody
A138542Ripertamab Biosimilar (Monoclonal, IgG1)

Popular Products